Listen: 2023 in review, CEO report cards, and a look at the year ahead
This week on "The Readout LOUD": What does it mean to a bad CEO? Can biotech endure another election year? And can you go to too many J.P. Morgan parties?
What does it mean to a bad CEO? Can biotech endure another election year? And can you go to too many J.P. Morgan parties?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our last episode of 2023, so we look back on the biggest stories of the year, discuss the best and worst CEOs in the industry, and make some reasonably informed guesses on what 2024 has in store for the drug industry.
What's Your Reaction?
